What have we learned from recent clinical trials in early breast cancer treatment?
How does olaparib affect the quality of life of breast cancer patients?
Biosimilar trastuzumab: a cost effective alternative for breast cancer treatment
Results of a Phase III trial on CT-P6, a trastuzumab biosimilar candidate, in early breast cancer
Oncotype DX testing to determine if a breast cancer patient will benefit from chemotherapy
AURORA – seeking to understand the genetic aberrations in metastatic breast cancer